(Q74618980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

The hepatorenal syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

L Dagher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K Moore

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

729-737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

Kidney, lower limb and whole-body uptake and release of catecholamines in alcoholic liver disease

12 November 2019

cites work

1 reference

12 December 2020

Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease

1 reference

12 December 2020

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

1 reference

12 December 2020

Increased production of cysteinyl leukotrienes in hepatorenal syndrome

1 reference

12 December 2020

Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.

1 reference

12 December 2020

Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

1 reference

12 December 2020

Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis

1 reference

12 December 2020

Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis

1 reference

12 December 2020

Prostaglandins: Modulators of Renal Function and Pressor Resistance in Chronic Liver Disease*

1 reference

12 December 2020

N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat.

1 reference

12 December 2020

Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure

1 reference

12 December 2020

Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney

1 reference

12 December 2020

Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis

1 reference

12 December 2020

Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome

1 reference

12 December 2020

Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis

1 reference

12 December 2020

Analysis of cysteinyl leukotrienes in human urine: enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome

1 reference

12 December 2020

Captopril in the hepatorenal syndrome

1 reference

12 December 2020

Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis

1 reference

12 December 2020

Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats.

1 reference

12 December 2020

Adverse effects of captopril in treatment of resistant ascites, a state of functional bilateral renal artery stenosis

1 reference

12 December 2020

Role of vasopressin in abnormal water excretion in cirrhotic patients

1 reference

12 December 2020

Systemic and regional hemodynamics in pre-ascitic cirrhosis

1 reference

12 December 2020

Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease

1 reference

12 December 2020

Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis.

1 reference

12 December 2020

Response to Dopamine Hydrochloride in the Hepatorenal Syndrome

1 reference

12 December 2020

Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion.

1 reference

12 December 2020

Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration

1 reference

12 December 2020

Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis

1 reference

12 December 2020

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

12 December 2020

Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium

1 reference

12 December 2020

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

1 reference

12 December 2020

Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis

1 reference

12 December 2020

Angiotensin II receptor antagonists in the pharmacological therapy of portal hypertension: a caution

1 reference

12 December 2020

Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease

1 reference

12 December 2020

Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction.

1 reference

12 December 2020

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor

1 reference

12 December 2020

Low-dose ornipressin improves renal function in the hepatorenal syndrome

1 reference

12 December 2020

Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver

1 reference

12 December 2020

Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

1 reference

12 December 2020

Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites

1 reference

12 December 2020

Elevated circulating plasma endothelin-1 concentrations in cirrhosis

1 reference

12 December 2020

Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?

1 reference

12 December 2020

Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration

1 reference

12 December 2020

Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors

1 reference

12 December 2020

Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume

1 reference

12 December 2020

Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cyclic AMP

1 reference

12 December 2020

Hepatorenal reflex regulating kidney function.

1 reference

12 December 2020

Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage

1 reference

12 December 2020

Circulating levels of endothelin in cirrhosis

1 reference

12 December 2020

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

12 December 2020

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

12 December 2020

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

1 reference

12 December 2020

ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

1 reference

12 December 2020

Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients.

1 reference

12 December 2020

Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition

1 reference

12 December 2020

Role of nitric oxide in gastrointestinal and hepatic function and disease

1 reference

12 December 2020

Regulation of the renal circulation

1 reference

12 December 2020

Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion

1 reference

12 December 2020

Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites

1 reference

12 December 2020

Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation

1 reference

12 December 2020

Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites

1 reference

12 December 2020

Endotoxemia in liver disease--time for re-appraisal?

1 reference

12 December 2020

Sympathetic modulation of renal autoregulation by carotid occlusion in conscious dogs.

1 reference

12 December 2020

Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome

1 reference

12 December 2020

Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release

1 reference

12 December 2020

Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome

1 reference

12 December 2020

Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats

1 reference

12 December 2020

Cysteinyl leukotrienes in the urine of patients with liver diseases

1 reference

12 December 2020

Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis

1 reference

12 December 2020

Renal prostaglandins and the control of renal function in liver disease

1 reference

12 December 2020

Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites

1 reference

12 December 2020

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

12 December 2020

Hepatorenal syndrome and ascites--an introduction

1 reference

12 December 2020

Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity

1 reference

12 December 2020

Renin-angiotensin-aldosterone system in cirrhosis

1 reference

12 December 2020

Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis

1 reference

12 December 2020

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1 reference

12 December 2020

Altered renal and platelet arachidonic acid metabolism in cirrhosis

1 reference

12 December 2020

The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis

1 reference

12 December 2020

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

12 December 2020

Increased synthesis of systemic prostacyclin in cirrhotic patients

1 reference

12 December 2020

Hepatorenal disorders: role of the sympathetic nervous system

1 reference

12 December 2020

Improvement in renal function in hepatorenal syndrome with N-acetylcysteine.

1 reference

12 December 2020

Increased nitric oxide—dependent vasorelaxation in aortic rings of cirrhotic rats with ascites

1 reference

12 December 2020

Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics

1 reference

12 December 2020

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

12 December 2020

Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity

1 reference

12 December 2020

Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients

1 reference

12 December 2020

Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure.

1 reference

12 December 2020

Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium

1 reference

12 December 2020

Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis.

1 reference

12 December 2020

Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis

1 reference

12 December 2020

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

1 reference

12 December 2020

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

12 December 2020

Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis

1 reference

12 December 2020

Is there still a need for albumin infusions to treat patients with liver disease?

1 reference

12 December 2020

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1 reference

12 December 2020

Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome

1 reference

12 December 2020

Amelioration of hepatorenal syndrome with selective endothelin-A antagonist

1 reference

12 December 2020

Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites.

1 reference

12 December 2020

Glucagon in portal hypertension

1 reference

12 December 2020

Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats

1 reference

12 December 2020

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

12 December 2020

Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia

1 reference

12 December 2020

The hepatorenal syndrome

1 reference

12 December 2020

Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver.

1 reference

12 December 2020

Prognostic significance of renal dysfunction in cirrhosis.

1 reference

12 December 2020

Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients

1 reference

12 December 2020

The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis

1 reference

12 December 2020

Endogenous factors involved in the control of arterial tone in cirrhosis.

1 reference

12 December 2020

Renal prostaglandins in cirrhosis of the liver

1 reference

12 December 2020

Urinary excretion of 6-keto-prostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites

1 reference

12 December 2020

Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences

1 reference

12 December 2020

Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide?

1 reference

12 December 2020

Hepatorenal syndrome--outcome after liver transplantation

1 reference

12 December 2020

Renal failure in Laennec's cirrhosis. II. Simultaneous determination of cardiac output and renal hemodynamics

1 reference

12 December 2020

Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome

1 reference

12 December 2020

Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.49.5.729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11600480%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

PubMed publication ID

11600480

1 reference